Zdrowie i gospodarka · 12/10/2011
FDA Releases Guidance for Industry on Labeling Warnings and Precautions for Human Prescription Drugs and Biologicals
The FDA has published a guidance document to help pharmaceutical companies create clear and consistent labeling for human prescription drugs and biological products, including warnings and precautions sections.
Source: Federal Register — Health and Human ServicesOpen original release →